Zentalis Pharmaceuticals Inc (ZNTL)
11.76
-0.81
(-6.44%)
USD |
NASDAQ |
Apr 24, 15:25
Zentalis Pharmaceuticals Cash from Operations (TTM): -207.82M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -207.82M |
September 30, 2023 | -204.55M |
June 30, 2023 | -199.09M |
March 31, 2023 | -162.84M |
December 31, 2022 | -163.75M |
September 30, 2022 | -163.44M |
June 30, 2022 | -163.73M |
March 31, 2022 | -166.82M |
December 31, 2021 | -154.09M |
Date | Value |
---|---|
September 30, 2021 | -144.43M |
June 30, 2021 | -131.50M |
March 31, 2021 | -107.42M |
December 31, 2020 | -86.82M |
September 30, 2020 | -72.66M |
June 30, 2020 | -62.08M |
March 31, 2020 | -47.01M |
December 31, 2019 | -39.14M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-207.82M
Minimum
Dec 2023
-39.14M
Maximum
Dec 2019
-133.95M
Average
-154.09M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Revolution Medicines Inc | -350.57M |
Day One Biopharmaceuticals Inc | -146.85M |
Perspective Therapeutics Inc | -36.91M |
Electromed Inc | 4.872M |
Xtant Medical Holdings Inc | -9.515M |